Clinical trial
Magnesium Effects in Apheresis
NCT00040235 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00040235 |
|---|---|
| Title | Magnesium Effects in Apheresis |
| Official title | Citrate Effects and Role of Prophylactic Magnesium Administration During Large-Volume Leukapheresis |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Procedure |
| Interventions | magnesium |
| Enrollment | 52 |
| Start date | Jun 1, 2002 |
| Completion | Feb 1, 2004 |
| First posted | Jun 24, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: